Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey A Kelman

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Vaccine|November 2, 2017
Driving immunization through the Medicare Annual Wellness Visit: A growing opportunityAngela K Shen, Rob Warnock, Jeffrey A Kelman
JAMA Internal Medicine|May 2, 2017
Dabigatran Compared With Rivaroxaban vs Warfarin-ReplyDavid J Graham, Michael Wernecke, Jeffrey A Kelman
The American Journal of Medicine|November 6, 2019
The ReplyDavid J Graham, Elande Baro, Michael Wernecke, et al.
Vaccine|June 18, 2018
Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013-2015Angela K Shen, Rob Warnock, Steve Chu, et al.
Human Vaccines & Immunotherapeutics|November 7, 2019
Patient characteristics of Medicare beneficiaries who report not getting influenza and pneumococcal vaccinations, 2001-2013Angela K Shen, Rob Warnock, Weston Selna, et al.
Vaccine|November 5, 2019
Characteristics of vaccinating providers reported through Medicare claims in office-based settings: Volume of influenza and pneumococcal vaccinationsAngela K Shen, Rob Warnock, Weston Selna, et al.
Vaccine|January 27, 2019
Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017Angela K Shen, Rob Warnock, Weston Selna, et al.
MMWR. Morbidity and Mortality Weekly Report|July 14, 2017
Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 YearsCarla L Black, Walter W Williams, Rob Warnock, et al.
American Journal of Preventive Medicine|February 22, 2015
Medicare claims versus beneficiary self-report for influenza vaccination surveillanceKimberly A Lochner, Marc A Wynne, Gloria H Wheatcroft, et al.
Pharmacoepidemiology and Drug Safety|August 18, 2011
Utilizing Medicare claims data for real‐time drug safety evaluations:is it feasible?Abraham G Hartzema, Judith A Racoosin, Thomas E MaCurdy, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Vaccine|November 2, 2017
Driving immunization through the Medicare Annual Wellness Visit: A growing opportunityAngela K Shen, Rob Warnock, Jeffrey A Kelman
JAMA Internal Medicine|May 2, 2017
Dabigatran Compared With Rivaroxaban vs Warfarin-ReplyDavid J Graham, Michael Wernecke, Jeffrey A Kelman
The American Journal of Medicine|November 6, 2019
The ReplyDavid J Graham, Elande Baro, Michael Wernecke, et al.
Vaccine|June 18, 2018
Receipt of other routinely recommended vaccines relative to receipt of seasonal influenza vaccines: Trends from medicare administrative data, 2013-2015Angela K Shen, Rob Warnock, Steve Chu, et al.
Human Vaccines & Immunotherapeutics|November 7, 2019
Patient characteristics of Medicare beneficiaries who report not getting influenza and pneumococcal vaccinations, 2001-2013Angela K Shen, Rob Warnock, Weston Selna, et al.
Vaccine|November 5, 2019
Characteristics of vaccinating providers reported through Medicare claims in office-based settings: Volume of influenza and pneumococcal vaccinationsAngela K Shen, Rob Warnock, Weston Selna, et al.
Vaccine|January 27, 2019
Vaccination among Medicare-fee-for service beneficiaries: Characteristics and predictors of vaccine receipt, 2014-2017Angela K Shen, Rob Warnock, Weston Selna, et al.
MMWR. Morbidity and Mortality Weekly Report|July 14, 2017
Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 YearsCarla L Black, Walter W Williams, Rob Warnock, et al.
American Journal of Preventive Medicine|February 22, 2015
Medicare claims versus beneficiary self-report for influenza vaccination surveillanceKimberly A Lochner, Marc A Wynne, Gloria H Wheatcroft, et al.
Pharmacoepidemiology and Drug Safety|August 18, 2011
Utilizing Medicare claims data for real‐time drug safety evaluations:is it feasible?Abraham G Hartzema, Judith A Racoosin, Thomas E MaCurdy, et al.
Pageof 8